sodium salicylate has been researched along with daunorubicin in 1 studies
Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (daunorubicin) | Trials (daunorubicin) | Recent Studies (post-2010) (daunorubicin) |
---|---|---|---|---|---|
2,031 | 50 | 171 | 8,239 | 886 | 1,310 |
Protein | Taxonomy | sodium salicylate (IC50) | daunorubicin (IC50) |
---|---|---|---|
72 kDa type IV collagenase | Homo sapiens (human) | 1.9 | |
Multidrug resistance-associated protein 1 | Homo sapiens (human) | 8 | |
Histone deacetylase 1 | Homo sapiens (human) | 0.047 | |
Histone deacetylase 8 | Homo sapiens (human) | 0.22 | |
Histone deacetylase 6 | Homo sapiens (human) | 0.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cammenga, J; Klampfer, L; Nimer, SD; Wisniewski, HG | 1 |
1 other study(ies) available for sodium salicylate and daunorubicin
Article | Year |
---|---|
Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines.
Topics: Amino Acid Chloromethyl Ketones; Annexin A5; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Caspase 3; Caspases; Cysteine Proteinase Inhibitors; Daunorubicin; Drug Synergism; Enzyme Activation; Gelsolin; Gene Expression Regulation, Leukemic; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; K562 Cells; Leukemia, Myeloid; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Poly(ADP-ribose) Polymerases; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Sodium Salicylate; Tumor Cells, Cultured | 1999 |